
Free Daily Podcast Summary
by Chris O'Brien
Welcome to Few & Far Between! Melissa Alesse, President of Biorasi, is your host for fascinating conversations - from clinical research and policymakers to biotech innovators and industry leaders.
The most recent episodes — sign up to get AI-powered summaries of each one.
Today on the Biorasi Few & Far Between Podcast: Host Melissa Alesse welcomes Jason Tardio, President and COO of Immunic Therapeutics, to the podcast to explore the biotech journey to R&D and commercialization. We'll also look into Immunic's novel treatments for multiple sclerosis, true team accountability, what makes biotech and big pharma so different. Watch this episode today!
Today on the Biorasi Few & Far Between podcast: Host Melissa Alesse welcomes Isaac Stoner, CEO of MindImmune Therapeutics, back to the podcast for a conversation on the evolving science of Alzheimer's disease and the challenges of biotech leadership. We'll explore Alzheimer's through the lens of the immune system, discuss drug development from the perspective of investors and operators, and dive into the power of networking in Boston's biotech ecosystem. And be sure to stick around for our lightning round - quick answers to important questions. Watch this episode today!
Today on the Biorasi Few & Far Between podcast: What's trending in the CRO market? Find out as host Melissa Alesse welcomes Joel White, owner of Marketcap Consulting and 20+ year veteran of the CRO industry. We'll uncover the latest in CRO strategy, biotech funding, and clinical trial program pricing. And be sure to stick around for our lightning round - quick answers to important questions. Watch this episode today!
Today on the Biorasi Few & Far Between podcast: Join new host Melissa Alesse and former host Chris O'Brien - CEO at Rancho BioSciences and Biorasi Board member - as they explore the origins and evolution of our podcast and what we've learned along the way.We dive deep into the importance of long-form media and thought leadership, AI's continuous evolution, and CROs from the CEO's POV.Watch this episode today!
Today on the Biorasi podcast, we look back on three years of AI innovation in healthcare and clinical trials - breaking new boundaries and a creating a new reality across all industries. Host Chris O'Brien welcomes back Zak Kohane, AI Oracle and Professor and Chair of Biomedical Informatics at Harvard Medical School. We'll journey back to Zak's first appearance on the podcast and take stock of what three years means to AI development including widespread adoption by patients and physicians, how cancer still outsmarts today's LLMs, and the importance of sharing prompts with fellow AI travellers. Find answers to the top AI questions in this new episode!
How do today’s CEOs and founders find the balance between planning and entrepreneurship? Check out the latest episode of the Biorasi Few & Far Between podcast - How Biotech Gets Built. Host Chris O'Brien welcomes Sinan Gölhan, CEO at GelTech Labs. We'll be exploring life in a biotech startup, hydrogels in lab robotics, and bringing AI into your organization. Watch this episode today!
Let's kick off 2026 with the first Biorasi podcast episode of the year! How do you get "Biotech Vision" to see the complete picture of your place in the industry? Find out in the latest episode of the Few & Far Between podcast - How Biotech Gets Built. Host Chris O'Brien welcomes guest Aoife Brennan, President and CEO of Climb Bio. We'll be discussing how to leverage science and strategy, the differences between CEOs and CMOs, and how hiring an "operational penknife" is critical to new organizations. Watch it today!
Are clinical trial protocols a true art form? Find out in a new episode of the Biorasi Few & Far Between podcast. Host Chris O'Brien welcomes guest Mark Ableson, founder of Ora Clinical and CRO pioneer. We'll be discussing exploratory endpoints, what to learn from failed trails, and essential factors in choosing a clinical site location. Listen today!
Free AI-powered daily recaps. Key takeaways, quotes, and mentions — in a 5-minute read.
Get Free Summaries →Free forever for up to 3 podcasts. No credit card required.
Podcasts in similar categories.

The Jamie Kern Lima Show
Entrepreneur Jamie Kern Lima interviews experts and celebrities about overcoming self-doubt and building self-belief.

The Mel Robbins Podcast
A motivational podcast offering research-backed tools and personal stories to help listeners make positive life changes.

We're Out of Time
Discusses the fentanyl crisis, mental health, and resilience through interviews with recovery experts, survivors, and public figures.

Hidden Brain
Explores human behavior and the unconscious patterns that shape our decisions, relationships, and society through science and storytelling.

Biohack-it
A weekly exploration of biohacking, holistic health, and science-driven strategies for optimizing physical and mental well-being.

Something You Should Know
Explores practical wisdom and expert insights to help listeners improve their lives, careers, and relationships.

Tony Mantor: Why Not Me ?
Explores autism, mental health, and human stories to promote understanding, challenge stigma, and support neurodiversity.

The Dylan Gemelli Podcast
Experts in health, fitness, and biohacking share science-backed strategies to improve well-being and performance.
Welcome to Few & Far Between! Melissa Alesse, President of Biorasi, is your host for fascinating conversations - from clinical research and policymakers to biotech innovators and industry leaders.
AI-powered recaps with compact key takeaways, quotes, and insights.
Get key takeaways from Few & Far Between: How Biotech Gets Built in a 5-minute read.
Stay current on your favorite podcasts without falling behind.
It's a free AI-powered email that summarizes new episodes of Few & Far Between: How Biotech Gets Built as soon as they're published. You get the key takeaways, notable quotes, and links & mentions — all in a quick read.
When a new episode drops, our AI transcribes and analyzes it, then generates a personalized summary tailored to your interests and profession. It's delivered to your inbox every morning.
No. Podzilla is an independent service that summarizes publicly available podcast content. We're not affiliated with or endorsed by Chris O'Brien.
Absolutely! The free plan covers up to 3 podcasts, any in the catalog. Basic raises that to 15, Pro to 40 and Max to 100. Browse our full catalog at /podcasts.
Few & Far Between: How Biotech Gets Built publishes monthly. Our AI generates a summary within hours of each new episode.
Few & Far Between: How Biotech Gets Built covers topics including Science, Fitness, Health & Fitness, Life Sciences. Our AI identifies the specific themes in each episode and highlights what matters most to you.
Free forever for up to 3 podcasts. No credit card required.
Free forever for up to 3 podcasts. No credit card required.